Apr 10, 2017 11:00 am UTC| Business
NEW YORK, April 10, 2017 -- Ovid Therapeutics, Inc., a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that...
ITG Releases March 2017 U.S. Trading Volume
Apr 10, 2017 10:59 am UTC| Business
NEW YORK, April 10, 2017 -- ITG (NYSE:ITG), a leading independent broker and financial technology provider, today announced that March 2017 U.S. trading volume was 3.7 billion shares and average daily volume (ADV) was...
VAALCO Energy Receives Continued Listing Standard Notice From NYSE
Apr 10, 2017 10:45 am UTC| Business
HOUSTON, April 10, 2017 -- VAALCO Energy, Inc. (NYSE:EGY) announced today that it had received notification on April 6, 2017, from the New York Stock Exchange (“NYSE”) that the price of the Company’s common stock has...
LINN Energy, Inc. Announces Listing on the OTCQB Market
Apr 10, 2017 10:45 am UTC| Business
HOUSTON, April 10, 2017 -- LINN Energy, Inc. (OTCQB:LNGG) announced today that its common stock has been approved for trading on the OTCQB market under the symbol LNGG. Investors can find real-time quotes and market...
Comstock Mining Announces Sweeping Master Plan and Zone Changes in Silver Springs Nevada
Apr 10, 2017 10:45 am UTC| Business
VIRGINIA CITY, Nev., April 10, 2017 -- Comstock Mining Inc. (“Comstock” or the “Company”) (NYSE MKT:LODE) announced today, that the Lyon County Board of Commissioners unanimously approved both a major,...
Apr 10, 2017 10:00 am UTC| Business
NEW YORK and MELBOURNE, Australia, April 10, 2017 -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that thePhase 3 trial ofits allogeneic mesenchymal precursor cell (MPC) product candidate MPC-150-IM in...
Nuo Therapeutics Appoints Dr. Paul D. Mintz to its Board of Directors
Apr 10, 2017 10:00 am UTC| Business
GAITHERSBURG, Md., April 10, 2017 -- Nuo Therapeutics, Inc. (OTCQX:AURX) (“Nuo” or the “Company”) announces the appointment of Paul D. Mintz, MD, Senior Vice President and Chief Medical Officer of Verax Biomedical, to...